KAYLIN REDINGER: Open Payments
NPI 1205245511 · JACKSONVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 14 payments from 9 companies in 2025. Trend: 2023 $345 · 2024 $398 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 3 | $62 |
| Lilly USA, LLC | 3 | $49 |
| ABBVIE INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 1 | $34 |
| PFIZER INC. | 1 | $18 |
| Novo Nordisk Inc | 1 | $17 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Ardelyx, Inc. | 1 | $16 |
Products named: TRELEGY ELLIPTA, MOUNJARO, VRAYLAR, REXULTI, PAXLOVID, Ozempic, VERQUVO, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
